Uždaroji akcinė bendrovė "CHEMI PHARM GROUP" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 606,658 |
| 101,110 |
| 27,732 |
| 19,728 |
| 3,288 |
| 34.76 |
| 3.25 |
| 311,671 |
| 26,284 |
| 30,403 |
| 307,552 |
| 2023 |
|---|
| 598,399 |
| 99,733 |
| 52,801 |
| 44,195 |
| 7,366 |
| 33.57 |
| 7.39 |
| 300,441 |
| 39,937 |
| 24,216 |
| 316,162 |
| 2024 |
|---|
| 739,711 |
| 123,285 |
| 30,670 |
| 21,311 |
| 3,552 |
| 32.17 |
| 2.88 |
| 255,936 |
| 29,860 |
| 20,103 |
| 265,693 |
Register and
explore Okredo data| 2024 |
|---|
| 739,711 |
| 123,285 |
| 30,670 |
| 21,311 |
| 3,552 |
| 32.17 |
| 2.88 |
| 255,936 |
| 29,860 |
| 20,103 |
| 265,693 |
Register and
explore Okredo data2024
Turnover (€)
739,711 €
24 % *
Sales per employee (€)
123,285 €24 % *
Profit before tax (€)
30,670 €
-42 % *
Net Profit (€)
21,311 €-52 % *
Profit per employee (€)
3,552 €-52 % *
Total profitability (%)
32.17 %-4.17 % *
Net profitability (%)
2.88 %-61.03 % *
Equity (€)
255,936 €-15 % *
Amounts Payable And Liabilities (€)
29,860 €
-25 % *
Non-current Assets (€)
20,103 €-17 % *
CurrentAssets (€)
265,693 €-16 % *